General MedicationsINJECTIONGeneric
LEVOFLOXACIN
LEVOFLOXACIN
Standard Dose
EQ 500MG/20ML (EQ 25MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview LEVOFLOXACIN is listed in Drugs@FDA under application 205968 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOFLOXACIN Form and strength INJECTABLE;INJECTION - EQ 500MG/20ML (EQ 25MG/ML) Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2024-09-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEVOFLOXACIN is listed in Drugs@FDA under application 205968 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOFLOXACIN Form and strength INJECTABLE;INJECTION - EQ 500MG/20ML (EQ 25MG/ML) Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2024-09-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.